Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) |
Common Stock [Member] |
Additional Paid-In Capital [Member] |
Accumulated Deficit [Member] |
Total Shareholders' Equity [Member] |
Non-controlling Interest [Member] |
Total |
---|---|---|---|---|---|---|
Beginning balance at Oct. 31, 2019 | $ 203,317 | $ 186,849,299 | $ (181,817,263) | $ 5,235,353 | $ (422,975) | $ 4,812,378 |
Beginning balance, shares at Oct. 31, 2019 | 20,331,754 | |||||
Stock option compensation to employees and directors | 963,880 | 963,880 | 963,880 | |||
Stock options and warrants issued to consultants | 57,454 | 57,454 | 57,454 | |||
Common stock issued upon exercise of stock options | $ 189 | 28,291 | 28,480 | 28,480 | ||
Common stock issued upon exercise of stock options, shares | 18,900 | |||||
Common stock issued in at-the-market offering | $ 4,907 | 1,747,076 | 1,751,983 | 1,751,983 | ||
Common stock issued in at-the-market offering, shares | 490,655 | |||||
Net loss | (2,592,543) | (2,592,543) | (24,032) | (2,616,575) | ||
Ending balance at Jan. 31, 2020 | $ 208,413 | 189,646,000 | (184,409,806) | 5,444,607 | (447,007) | 4,997,600 |
Ending balance, shares at Jan. 31, 2020 | 20,841,309 | |||||
Beginning balance at Oct. 31, 2020 | $ 242,486 | 200,354,488 | (191,835,618) | 8,761,356 | (496,983) | 8,264,373 |
Beginning balance, shares at Oct. 31, 2020 | 24,248,695 | |||||
Stock option compensation to employees and directors | 874,862 | 874,862 | 874,862 | |||
Stock options and warrants issued to consultants | 111,237 | 111,237 | 111,237 | |||
Common stock issued upon exercise of stock options | $ 299 | 103,925 | 104,224 | 104,224 | ||
Common stock issued upon exercise of stock options, shares | 29,880 | |||||
Common stock issued in at-the-market offering | $ 19,006 | 5,937,590 | 5,956,596 | 5,956,596 | ||
Common stock issued in at-the-market offering, shares | 1,900,547 | |||||
Net loss | (2,208,291) | (2,208,291) | (24,086) | (2,232,377) | ||
Ending balance at Jan. 31, 2021 | $ 261,791 | $ 207,382,102 | $ (194,043,909) | $ 13,599,984 | $ (521,069) | $ 13,078,915 |
Ending balance, shares at Jan. 31, 2021 | 26,179,122 |
X | ||||||||||
- Definition Stock options and warrants issued to consultants. No definition available.
|
X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. No definition available.
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of stock issued as a result of the exercise of stock options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|